Form 4: SPX Technologies CEO Reports Stock Grant, Tax-Related Sale
Insider Transaction Report
SPX Technologies CEO Eugene Joseph Lowe III reported an acquisition of 14,619 common shares from a performance-based grant and a disposition of 22,562 shares for tax withholding, alongside existing stock options.
Summary
- Eugene Joseph Lowe III, Director, President, and CEO of SPX Technologies, Inc. (SPXC), reported transactions on February 24, 2026.
- Acquired 14,619 shares of common stock as a grant under the SPX 2019 Stock Compensation Plan for performance during the 2023-2025 period.
- Disposed of 22,562 shares of common stock at $237.18 per share to cover withholding taxes upon the vesting of previously granted restricted stock units.
- Following these transactions, Lowe III directly beneficially owns 765,129 shares of common stock, which includes unvested restricted stock units.
- Additionally, 5,035 shares are indirectly beneficially owned through a 401(k) Plan.
- The filing also details various employee stock options held by Lowe III, with exercise prices ranging from $27.40 to $138.60 and expiration dates extending to March 3, 2035.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this filing as moderately positive due to the performance-based stock grant to the CEO, indicating achieved company objectives, while the tax-related sale is a routine event.
Positives
- Grant of 14,619 shares of common stock to the CEO indicates achievement of performance targets for the 2023-2025 period under the SPX 2019 Stock Compensation Plan.
Negatives
- Disposition of 22,562 shares of common stock for tax withholding purposes, reducing direct beneficial ownership.
Industry Context
StockSavvy.ai notes that insider transactions, particularly grants tied to performance, can signal management's confidence in future company performance and alignment with shareholder interests. Tax-related sales are common and typically not indicative of a change in sentiment.
Comparison to Industry Standards
- Form 4 filings are standard regulatory disclosures for insider transactions.
- The grant of shares for performance is a common executive compensation practice across industries, aligning executive incentives with company performance.
- The subsequent sale of shares to cover tax obligations upon vesting is also a routine event and not unique to SPX Technologies or its sector.
Related Party Transactions
- Grant of 14,619 common shares to CEO Eugene Joseph Lowe III under the SPX 2019 Stock Compensation Plan for performance during the 2023-2025 period.
- Disposition of 22,562 common shares by CEO Eugene Joseph Lowe III to the issuer for payment of withholding taxes upon RSU vesting.
Stakeholder Impact
- Shareholders: The performance-based grant to the CEO aligns management incentives with shareholder value creation, as it signifies the achievement of company performance targets.
- Employees: The stock compensation plan is a standard mechanism for executive incentives, potentially setting a precedent or reflecting the company's approach to rewarding leadership.
Key Dates
| Date | Description |
|---|---|
| 03/01/2018 | Start of vesting for employee stock options with $27.40 exercise price. |
| 02/22/2019 | Start of vesting for employee stock options with $32.69 exercise price. |
| 02/21/2020 | Start of vesting for employee stock options with $36.51 exercise price. |
| 03/01/2020 | Grant date for employee stock options with $27.40 exercise price. |
| 02/20/2021 | Start of vesting for employee stock options with $50.09 exercise price. |
| 02/22/2021 | Grant date for employee stock options with $32.69 exercise price. |
| 02/21/2022 | Grant date for employee stock options with $36.51 exercise price. |
| 03/01/2022 | Start of vesting for employee stock options with $58.34 exercise price. |
| 02/20/2023 | Grant date for employee stock options with $50.09 exercise price. |
| 03/01/2023 | Start of vesting for employee stock options with $48.97 exercise price. |
| 03/01/2024 | Grant date for employee stock options with $58.34 exercise price. |
| 03/01/2024 | Start of vesting for employee stock options with $71.93 exercise price. |
| 02/28/2025 | Start of vesting for employee stock options with $116.40 exercise price. |
| 03/01/2025 | Grant date for employee stock options with $48.97 exercise price. |
| 02/17/2026 | Execution date of Power of Attorney by Eugene Joseph Lowe III. |
| 02/24/2026 | Acquisition and disposition of common stock by Eugene Joseph Lowe III. |
| 02/26/2026 | Signature date of the Form 4 filing. |
| 03/01/2026 | Grant date for employee stock options with $71.93 exercise price. |
| 03/03/2026 | Start of vesting for employee stock options with $138.60 exercise price. |
| 03/01/2027 | Expiration date for employee stock options with $27.40 exercise price. |
| 02/28/2027 | Grant date for employee stock options with $116.40 exercise price. |
| 02/22/2028 | Expiration date for employee stock options with $32.69 exercise price. |
| 03/03/2028 | Grant date for employee stock options with $138.60 exercise price. |
| 02/21/2029 | Expiration date for employee stock options with $36.51 exercise price. |
| 02/20/2030 | Expiration date for employee stock options with $50.09 exercise price. |
| 03/01/2031 | Expiration date for employee stock options with $58.34 exercise price. |
| 03/01/2032 | Expiration date for employee stock options with $48.97 exercise price. |
| 03/01/2033 | Expiration date for employee stock options with $71.93 exercise price. |
| 02/28/2034 | Expiration date for employee stock options with $116.40 exercise price. |
| 03/03/2035 | Expiration date for employee stock options with $138.60 exercise price. |
Recommendation
holdThe filing details routine insider transactions, including a performance-based stock grant to the CEO, which is a positive indicator of achieved company objectives. However, the concurrent tax-related sale is a common event and does not signal a change in fundamental outlook. Without additional financial or strategic information, a 'hold' recommendation is appropriate as these transactions do not significantly alter the investment thesis for SPX Technologies.
Keywords
SPX Technologies, SPXC, Form 4, Insider Trading, Stock Compensation, CEO Stock, Equity Grant, Tax Withholding, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.